Long-Term Management of Moderate-to-Severe Plaque Psoriasis: Maintenance of Treatment Success Following Cessation of Halobetasol Propionate 0.01%/Tazarotene 0.045% Lotion. (2020). SKIN The Journal of Cutaneous Medicine, 4(6), s79. https://doi.org/10.25251/skin.4.supp.79